Abria Magee, senior program manager for the Cancer Prevention and Research Institute of Texas, gave an overview of the agency’s efforts to fuel innovation in cancer research and drive advancements in prevention and cures at the recent AI in Health Conference hosted by Rice’s Ken Kennedy Institute.
Rice is part of multiuniversity research team that has secured $34.9 million from ARPA-H to accelerate the development of a bioelectronic implant designed to revolutionize treatment for obesity and Type 2 diabetes, improving patient experience and outcomes while reducing the development and manufacturing costs.
Rice’s Ken Kennedy Institute hosted the third annual AI in Health Conference Sept. 9-12, welcoming over 470 participants to Houston to explore the latest advancements in artificial intelligence.
A team of Rice engineering students was awarded the top prize in a prestigious national design competition for its innovative medical device for urological care.
Rice and Baylor College of Medicine have received $2.8 million from the NIH for research on reducing inflammation and lung damage in acute respiratory distress syndrome patients.
Rice and the University of Texas MD Anderson Cancer Center today announced the launch of the Center for Operations Research in Cancer, a joint initiative to solve complex challenges in cancer care using data science to make better operational decisions.
Rice’s Ken Kennedy Institute is hosting the third annual AI in Health Conference Sept. 9-12 with themes this year including foundation models in medicine, LLM applications, AI in neuroscience and neurotechnology, digital twins in health care and patient engagement and equity in health AI.
Rice and the University of Texas MD Anderson Cancer Center today announced the creation of the Cancer Bioengineering Collaborative to develop innovative technologies and bioengineering approaches to improve cancer research, diagnosis and treatment.
Rice University’s Synthesis X Center (SynthX) and Baylor College of Medicine’s Dan L Duncan Comprehensive Cancer Center have jointly awarded their first innovation seed grants to three teams of research collaborators from Rice and Baylor.
Rice has created the new Synthesis X Center to bring together clinicians treating cancer and researchers looking for cures to help spur drug discovery make precision adjustments to drug properties and translate fundamental research discoveries into clinical applications.
Rice engineer Jacob Robinson participated in the first “Houston Day: Beyond the Bayou” program organized by the Greater Houston Partnership, which brought together state legislators from across Texas for a two-day legislative advocacy event in Houston earlier this month.
Rice University researchers in the lab of chemist Han Xiao have identified a promising new immunological pathway to treat stubborn bone tumors, one of most prevalent forms of metastases in breast cancer patients.
Rice University has launched its Medical Humanities Research Institute, the only institute in the United States and one of few in the world solely dedicated to advancing translational research on human experiences of health and illness.
The Advanced Research Projects Agency for Health has awarded a Rice-led team $45 million to rapidly develop an implant with sense-and-respond technology that could slash U.S. cancer-related deaths by more than 50%.